oru.sePublikationer
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Neisseria gonorrhoeae Strain with High-Level Resistance to Spectinomycin Due to a Novel Resistance Mechanism (Mutated Ribosomal Protein S5) Verified in Norway
Orebro University Hospital. WHO Collaborating Ctr Gonorrhoea & Other STIs, Dept Lab Med, Swedish Reference Lab Pathogen Neisseria, Orebro, Sweden..
Orebro Univ Hosp, WHO Collaborating Ctr Gonorrhoea & Other STIs, Dept Lab Med, Swedish Reference Lab Pathogen Neisseria, Orebro, Sweden..
Univ Hosp N Norway, Dept Infect Dis, Tromso, Norway.;Univ Tromso, Inst Clin Med, Tromso, Norway..
Oslo Univ Hosp, Olafiaklin, Oslo, Norway.;Univ Oslo, Inst Clin Med, Oslo, Norway..
Show others and affiliations
2013 (English)In: Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, E-ISSN 1098-6596, Vol. 57, no 2, 1057-1061 p.Article in journal (Refereed) Published
Abstract [en]

Gonorrhea may become untreatable, and new treatment options are essential. Verified resistance to spectinomycin is exceedingly rare. However, we describe a high-level spectinomycin-resistant (MIC, >1,024 mu g/ml) Neisseria gonorrhoeae strain from Norway with a novel resistance mechanism. The resistance determinant was a deletion of codon 27 (valine) and a K28E alteration in the ribosomal protein 5S. The traditional spectinomycin resistance gene (16S rRNA) was wild type. Despite this exceedingly rare finding, spectinomycin available for treatment of ceftriaxone-resistant urogenital gonorrhea would be very valuable.

Place, publisher, year, edition, pages
2013. Vol. 57, no 2, 1057-1061 p.
National Category
Microbiology in the medical area Pharmacology and Toxicology
Identifiers
URN: urn:nbn:se:oru:diva-56782DOI: 10.1128/AAC.01775-12ISI: 000313896500051PubMedID: 23183436OAI: oai:DiVA.org:oru-56782DiVA: diva2:1084087
Available from: 2017-03-23 Created: 2017-03-23 Last updated: 2017-03-23Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Unemo, Magnus
By organisation
Orebro University Hospital
In the same journal
Antimicrobial Agents and Chemotherapy
Microbiology in the medical areaPharmacology and Toxicology

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 3 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf